Products & Technology
Products & Technology
The Interventional Cardiology and Critical Care Products divisions both have track records of innovation in the development of next-generation medical technologies that make a difference in patients’ lives. A worldwide sales and marketing team and a network of distributors deliver our products to where they can help most.
The Interventional Cardiology division is focused on the development, manufacture and commercialization of drug-eluting stents, bare metal stents and angioplasty catheters.
BioMatrix Flex™, BioMatrix NeoFlex™ and Axxess™ both incorporate Biosensors’ unique abluminal biodegradable polymer coating, which is absorbed after 6 to 9 months*.
BioMatrix Flex™and BioMatrix NeoFlex™combines the established safety of a DES with an abluminal biodegradable polymer, the proven efficacy of the BA9™ drug and an advanced stent design providing enhanced deliverability1; through improved trackability and improved flexibility2.
Axxess™ is Biosensors' self-expanding bifurcation DES, featuring our abluminal4 biodegradable PLA coating and proprietary BA9™ drug.
The latest generation bare metal stent, Gazelle™3, has been developed using the proprietary Quadrature Link™ design for enhanced flexibility.
Available in a broad range of sizes, the proven stent platform provides the deliverability necessary for easy positioning.
Powerline™ offers excellent trackability and crossability for the treatment of complex lesions.
The unique automated MultiPleat™ folding technology provides consistently low primary and secondary profiles to facilitate treatment of multi-vessel disease.
Critical Care Products
The Critical Care Products division develops and manufactures vascular catheters, pressure monitoring kits, arterial blood sampling kits and blood pressure transducers for use in open heart surgery and critical care areas of the hospital.
| * | In vivo testing in porcine model demonstrates abluminal coating is absorbed after 6 to 9 months. Data on file at Biosensors International. |
| 1. | Deliverability defined as a combination of flexibility, trackability and pushability. |
| 2. | Compared to the BioMatrix™ stent platform – Internal bench testing – Flexibility and trackability: n=15 in each group, 3.0x28 mm stents – Side branch access: n=2 in each group, 3.0x28mm/3.0x18 mm stents – Bench test results may not necessarily be indicative of clinical outcomes. |
| 3. | Commercialized under the name S-Stent™ in Japan. |
| 4. | The coating is applied primarily on the abluminal surface |
CAUTION: The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.
Biosensors’ interventional cardiology products, including BioMatrix Flex™, BioMatrix™, Axxess™, BioFreedom™, Gazelle™, Juno™, S-Stent™, Powerline™, Quadrature Link™ and MultiPleat™, are not available for sale in the United States and certain other countries. BioFreedom™ is an investigational device. All other trademarks are the property of their respective owners.
BioMatrix Flex, BioMatrix, Axxess, BioFreedom, Gazelle, Juno, S-Stent, Powerline, Quadrature Link and MultiPleat are trademarks or registered trademarks of Biosensors International Group, Ltd. in the United States and certain other countries. All cited trademarks are the property of their respective owners.